Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002.

Standard

Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. / de Pedro-Cuesta, Jesús; Glatzel, Markus; Almazán, Javier; Stoeck, Katharina; Mellina, Vittorio; Puopolo, Maria; Pocchiari, Maurizio; Zerr, Inga; Kretszchmar, Hans A; Brandel, Jean-Philippe; Delasnerie-Lauprêtre, Nicole; Alpérovitch, Annick; Cornelia, Van Duijn; Sanchez-Juan, Pascual; Collins, Steven; Lewis, Victoria; Jansen, Gerard H; Coulthart, Michael B; Gelpi, Ellen; Budka, Herbert; Mitrova, Eva.

In: BMC PUBLIC HEALTH, Vol. 6, 2006, p. 278.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

de Pedro-Cuesta, J, Glatzel, M, Almazán, J, Stoeck, K, Mellina, V, Puopolo, M, Pocchiari, M, Zerr, I, Kretszchmar, HA, Brandel, J-P, Delasnerie-Lauprêtre, N, Alpérovitch, A, Cornelia, VD, Sanchez-Juan, P, Collins, S, Lewis, V, Jansen, GH, Coulthart, MB, Gelpi, E, Budka, H & Mitrova, E 2006, 'Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002.', BMC PUBLIC HEALTH, vol. 6, pp. 278. https://doi.org/10.1186/1471-2458-6-278

APA

de Pedro-Cuesta, J., Glatzel, M., Almazán, J., Stoeck, K., Mellina, V., Puopolo, M., Pocchiari, M., Zerr, I., Kretszchmar, H. A., Brandel, J-P., Delasnerie-Lauprêtre, N., Alpérovitch, A., Cornelia, V. D., Sanchez-Juan, P., Collins, S., Lewis, V., Jansen, G. H., Coulthart, M. B., Gelpi, E., ... Mitrova, E. (2006). Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. BMC PUBLIC HEALTH, 6, 278. https://doi.org/10.1186/1471-2458-6-278

Vancouver

Bibtex

@article{19db5217937d45678d237ec1fdda608c,
title = "Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002.",
abstract = "BACKGROUND: The objective of this study was to describe the diagnostic panorama of human transmissible spongiform encephalopathies across 11 countries. METHODS: From data collected for surveillance purposes, we describe annual proportions of deaths due to different human transmissible spongiform encephalopathies in eleven EUROCJD-consortium countries over the period 1993-2002, as well as variations in the use of diagnostic tests. Using logistic models we quantified international differences and changes across time. RESULTS: In general, pre-mortem use of diagnostic investigations increased with time. International differences in pathological confirmation of sporadic Creutzfeldt-Jakob disease, stable over time, were evident. Compared to their counterparts, some countries displayed remarkable patterns, such as: 1) the high proportion, increasing with time, of variant Creutzfeldt-Jakob disease in the United Kingdom, (OR 607.99 95% CI 84.72-4363.40), and France (OR 18.35, 95% CI 2.20-152.83); 2) high, decreasing proportions of iatrogenic Creutzfeldt-Jakob disease in France, (OR 5.81 95% CI 4.09-8.24), and the United Kingdom, (OR 1.54 95% CI 1.03-2.30); and, 3) high and stable ratios of genetic forms in Slovakia (OR 21.82 95% CI 12.42-38.33) and Italy (OR 2.12 95% CI 1.69-2.68). CONCLUSION: Considerable international variation in aetiological subtypes of human transmissible spongiform encephalopathies was evident over the observation period. With the exception of variant Creutzfeldt-Jakob disease and iatrogenic Creutzfeldt-Jakob disease in France and the United Kingdom, these differences persisted across time.",
author = "{de Pedro-Cuesta}, Jes{\'u}s and Markus Glatzel and Javier Almaz{\'a}n and Katharina Stoeck and Vittorio Mellina and Maria Puopolo and Maurizio Pocchiari and Inga Zerr and Kretszchmar, {Hans A} and Jean-Philippe Brandel and Nicole Delasnerie-Laupr{\^e}tre and Annick Alp{\'e}rovitch and Cornelia, {Van Duijn} and Pascual Sanchez-Juan and Steven Collins and Victoria Lewis and Jansen, {Gerard H} and Coulthart, {Michael B} and Ellen Gelpi and Herbert Budka and Eva Mitrova",
year = "2006",
doi = "10.1186/1471-2458-6-278",
language = "Deutsch",
volume = "6",
pages = "278",
journal = "BMC PUBLIC HEALTH",
issn = "1471-2458",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002.

AU - de Pedro-Cuesta, Jesús

AU - Glatzel, Markus

AU - Almazán, Javier

AU - Stoeck, Katharina

AU - Mellina, Vittorio

AU - Puopolo, Maria

AU - Pocchiari, Maurizio

AU - Zerr, Inga

AU - Kretszchmar, Hans A

AU - Brandel, Jean-Philippe

AU - Delasnerie-Lauprêtre, Nicole

AU - Alpérovitch, Annick

AU - Cornelia, Van Duijn

AU - Sanchez-Juan, Pascual

AU - Collins, Steven

AU - Lewis, Victoria

AU - Jansen, Gerard H

AU - Coulthart, Michael B

AU - Gelpi, Ellen

AU - Budka, Herbert

AU - Mitrova, Eva

PY - 2006

Y1 - 2006

N2 - BACKGROUND: The objective of this study was to describe the diagnostic panorama of human transmissible spongiform encephalopathies across 11 countries. METHODS: From data collected for surveillance purposes, we describe annual proportions of deaths due to different human transmissible spongiform encephalopathies in eleven EUROCJD-consortium countries over the period 1993-2002, as well as variations in the use of diagnostic tests. Using logistic models we quantified international differences and changes across time. RESULTS: In general, pre-mortem use of diagnostic investigations increased with time. International differences in pathological confirmation of sporadic Creutzfeldt-Jakob disease, stable over time, were evident. Compared to their counterparts, some countries displayed remarkable patterns, such as: 1) the high proportion, increasing with time, of variant Creutzfeldt-Jakob disease in the United Kingdom, (OR 607.99 95% CI 84.72-4363.40), and France (OR 18.35, 95% CI 2.20-152.83); 2) high, decreasing proportions of iatrogenic Creutzfeldt-Jakob disease in France, (OR 5.81 95% CI 4.09-8.24), and the United Kingdom, (OR 1.54 95% CI 1.03-2.30); and, 3) high and stable ratios of genetic forms in Slovakia (OR 21.82 95% CI 12.42-38.33) and Italy (OR 2.12 95% CI 1.69-2.68). CONCLUSION: Considerable international variation in aetiological subtypes of human transmissible spongiform encephalopathies was evident over the observation period. With the exception of variant Creutzfeldt-Jakob disease and iatrogenic Creutzfeldt-Jakob disease in France and the United Kingdom, these differences persisted across time.

AB - BACKGROUND: The objective of this study was to describe the diagnostic panorama of human transmissible spongiform encephalopathies across 11 countries. METHODS: From data collected for surveillance purposes, we describe annual proportions of deaths due to different human transmissible spongiform encephalopathies in eleven EUROCJD-consortium countries over the period 1993-2002, as well as variations in the use of diagnostic tests. Using logistic models we quantified international differences and changes across time. RESULTS: In general, pre-mortem use of diagnostic investigations increased with time. International differences in pathological confirmation of sporadic Creutzfeldt-Jakob disease, stable over time, were evident. Compared to their counterparts, some countries displayed remarkable patterns, such as: 1) the high proportion, increasing with time, of variant Creutzfeldt-Jakob disease in the United Kingdom, (OR 607.99 95% CI 84.72-4363.40), and France (OR 18.35, 95% CI 2.20-152.83); 2) high, decreasing proportions of iatrogenic Creutzfeldt-Jakob disease in France, (OR 5.81 95% CI 4.09-8.24), and the United Kingdom, (OR 1.54 95% CI 1.03-2.30); and, 3) high and stable ratios of genetic forms in Slovakia (OR 21.82 95% CI 12.42-38.33) and Italy (OR 2.12 95% CI 1.69-2.68). CONCLUSION: Considerable international variation in aetiological subtypes of human transmissible spongiform encephalopathies was evident over the observation period. With the exception of variant Creutzfeldt-Jakob disease and iatrogenic Creutzfeldt-Jakob disease in France and the United Kingdom, these differences persisted across time.

U2 - 10.1186/1471-2458-6-278

DO - 10.1186/1471-2458-6-278

M3 - SCORING: Zeitschriftenaufsatz

VL - 6

SP - 278

JO - BMC PUBLIC HEALTH

JF - BMC PUBLIC HEALTH

SN - 1471-2458

ER -